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Abstract – Cyrene as a bio-alternative solvent: a highly efficient, waste minimizing protocol for the synthesis of ureas 
from isocyanates and secondary amines in the bio-available solvent Cyrene is reported. This method eliminated the use 
of toxic solvents, such as DMF, and established a simple work-up procedure for removal of the Cyrene, which led to a 
28-fold increase in molar efficiency versus industrial standard protocols.  
 
Introduction - Ureas are an important class of compound that have been exploited in a number of fields, such as 
pharmaceuticals, agrochemicals and materials science. In the pharmaceutical sector the utility of ureas can be observed 
in the variety of biological activities that they exhibit.1 For example, ureas are found in anti-malaria compounds,2 
hepatitis C protease inhibitors,3 HIV-protease inhibitors,4 anti-obesity therapeutics,5 anticancer agents,6 antibiotics,7 
anticonvulsants8 and antimicrobials9 (Figure 1). Furthermore, ureas themselves are increasingly exploited as catalysts,10 
ligands,11 reagents,12 solvents13 and substrates14 for a multitude of synthetic transformations. 
 
 
 
Figure 1. Biologically active ureas  
 
Due to their importance a variety of methods have been developed for the synthesis of ureas,15 with a recent emphasis 
on developing greener, more sustainable processes.16,17 One of the most common ways to synthesize ureas is from the 
reaction of isocyanates with amines. For example, a series of phenyl isocyanates 1 was reacted with N-aryl-NH-
piperazine 2 to give a series of ureas 3 that was screened for inhibition of platelet-derived growth factor receptor 
phosphorylation (Figure 2, eq. 1).18 In this typical example using DMF as solvent, a variety of ureas 3 were formed in 
good yields, though extended reaction times and extensive work-up / purification procedures needed to be employed. 
Whilst this reaction can be carried out in a variety of different solvents / reaction media, nearly 80% of the reactions in 
the literature use DMF or halogenated solvents.19 There are strong environmental, safety and regulatory pressures to 
minimize the use of solvents that are designated as being high risk. Replacement for dipolar aprotic solvents,20 such as 
problematic solvents DMF, NMP and DMAc, was recently highlighted as a priority within the pharmaceutical 
industry.21 In turn, companies and academic researchers have put significant amounts of time, effort and expense into 
the development of more sustainable chemical processes that do not rely on high risk solvents.22,23 A possible 
alternative to DMF and other polar aprotic solvents is Cyrene (7, dihydrolevoglucosenone, Figure 2).24 Cyrene is 
synthesised in a two-step process from waste cellulose.25,26 Importantly, it has similar physical properties to other 
dipolar aprotic solvents, including DMF. The viability of Cyrene as a DMF replacement was recently demonstrated by 
Watson et al. in palladium mediated cross-coupling reactions.27 In addition, Cyrene28,29 was shown to be an effective 
solvent in SN2 and SNAr reactions24 as well as for the synthesis of MOFs.30 Interestingly, the use of Cyrene as a solvent 
for the addition of a nucleophile to a carbonyl has not been investigated despite the fact that these processes are known 
to be promoted by polar aprotic solvents.31 Herein, we present the development and scope of the use of the bio-available 
solvent Cyrene (7) for the synthesis of ureas 6 from the reaction of isocyanates 4 with amines 5 (Figure 2, eq. 2). An 
emphasis was placed on minimizing the amount of waste produced during the work-up, isolation and purification of the 
product. 
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Figure 2. Reaction of isocyanates and amines in DMF and Cyrene. 
 
Results and Discussion - To begin the investigation, the reaction of phenylisocyanate (4a) and pyrrolidine (5a) in 
Cyrene (7) was investigated (Scheme 1). Whilst the optimization of the reaction was straightforward, the isolation of 
the pure urea was more problematic. In order to minimize by-products, the reagents were added together at 0 °C and 
allowed to warm to rt for 1 h. This protocol allowed for the development of a general procedure for both electron rich 
and electron deficient isocyanates (vide infra). Initially, the product was isolated by the addition of water and 
dichloromethane, liquid-liquid extraction, washing with water / brine, drying over magnesium sulphate and purified by 
column chromatography (hexanes/ethyl acetate). This extended procedure resulted in a high yield of the desired urea 6a, 
90%, but also led to a significant amount of waste in the form of organic solvents and contaminated aqueous waste. In 
addition, the Cyrene was found to co-elute with the product and additional column purification was sometimes required 
in order to get pure compounds. In order to minimize the use of organic solvents as well as the amount of waste 
produced in the isolation of the product, it was decided to examine alternative work-up procedures. The use of various 
acid/base work-up procedures all led to decomposition of both the urea and Cyrene. Finally, it was found that the 
addition of water to the Cyrene solution at the conclusion of the reaction resulted in precipitation of the desired urea. 
Filtration and washing with water gave analytically pure N-phenylpyrrolidine-1-carboxamide (6a) in a synthetically 
useful yield of 80% (cf. Scheme 2).  
 
 
Scheme 1. Optimization of the synthesis of urea 6a in Cyrene. 
 
In order to access the efficieny of the two protocols, molar efficiency calculations were undertaken using the method of 
Watson et al.32 in which: 
 
molar efficiency (Mol. E%) = [moles product / moles starting material + additives + catalysts + solvents] x 100 
 
The Mol. E% was calculated for each step of the process and the total molar efficiency (molEtotal) is the multiplication 
of these values. Comparison of the molar efficiency of our original process, which was based on the industrial standard 
protocol, versus the optimized water washing method showed that use of the latter gave a 28-fold increase in molar 
efficiency (Figure 3).33 Similar water addition work-up procedures have been employed to help minimize the E-
factors.34 This simple procedure also removed all of the Cyrene from the product, which has been shown to be one of 
the key challenges of using this solvent.27 Importantly, this method allowed for elimination of all non-bioderived 
solvents from the process with only Cyrene and water required. 
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Figure 3. Comparison of molar efficiency for the synthesis of ureas in Cyrene 
 
With the optimized reaction and isolation procedure in hand the scope of the reaction of amines with phenyl isocyanates 
(4a) in Cyrene was examined (Scheme 2). A variety of secondary cyclic 5a-d and acyclic amines 5e-n were subjected 
to the reaction conditions.35 It was found that in addition to pyrrolidine (5a), cyclic amines piperidine (5b), morpholine 
(5c) and 1,2,3,4-tetrahydroisoquinoline (5d) gave the desired ureas, 6a-d in good yield. N,N-Dialkyl amines 5e-j with 
chain length between 2-8 carbons afforded ureas 6e-j in good yields. In addition, N,N-dicyclohexylamine (5k) gave 
urea 6k in 87% yield. Next, unsymmetrical secondary amines were subjected to the reaction conditions. Both N-methyl-
N-allylamine (5l) and N-methylaniline (5m) gave the desired ureas, 6l and 6m, in good yields when subjected to the 
standard conditions. Finally, bis-N-allylamine (5n) afforded 1,1-diallyl-3-phenylurea (6n) in excellent yield when 
reacted with phenyl isocyanate (4a). 
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 Scheme 2. Synthesis of ureas 6 from phenyl isocyanate 4a and amines 5 in Cyrene 7. 
 
Next, the effects of a substituent on the aryl isocyanates were investigated. Thus, a series of substituted aryl isocyanates 
4 were reacted with pyrrolidine (5a) to give ureas 6o-u (Scheme 3). Using the optimized conditions for phenyl 
isocyanate (4a) afforded the desired ureas 6o-u in moderate to good yield. Having an electron-withdrawing group at the 
4-position, such as in 4-fluoro-, 4-chloro- and 4-nitrophenyl isocyanates (4b-d), led to increased yields relative to the 
more electron rich 4-methoxyphenyl isocyanate. The use of 2-fluorophenyl isocyanate gave the desired urea 6t in a 
lower yield than the 4-fluorophenyl isocyanate isomer. This result suggests that the steric hindrance imposed by having 
an ortho substituent on the aromatic ring leads to a decrease in yield. Finally, 4-fluorophenyl isocyanate was reacted 
with N-methylaniline under the standard conditions to give 1-methyl-1,3-diphenylurea (6u) in good yield. 
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Scheme 3. Effect of substituent on isocyanate reactivity 
 
In situ 19F NMR was used to compare the rate of the formation of ureas from isocyanates and amines in Cyrene versus 
the industrial standard solvents DMF and CH2Cl2. The room temperature reaction of 4-fluorophenyl isocyanate (4b) and 
pyrrolidine (5a) to give urea 6o in the three solvents of interest was monitored by NMR spectroscopy. All of the 
reactions were found to be complete in less than 5 minutes when run at 1 M concentration. The relatively fast rates of 
these reactions is due to the activating 4-fluoro moiety on the phenyl isocyanate. Importantly, this analysis provided 
further support for the viability of Cyrene to replace the industrial standard solvents DMF and CH2Cl2 in this process.  
Conclusions 
In summary, a green, mild and efficient approach towards the synthesis of ureas from aryl isocyanates and secondary 
amines in the bio-alternative solvent Cyrene was developed. Both the scope of the amine nucleophile and the effect of 
substitution on the aryl isocyanate were investigated. This method provides an important alternative to the current 
industrial use of DMF and halogenated solvents for this process. Importantly, it eliminates the need for the use of both 
these toxic solvents as well as any non-bioderived organic solvent. Of even more importance is the fact that simply 
treating the reaction mixture with water solved one of the key problems associated with the use of Cyrene as a solvent, 
its removal from the product. 
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